ArticlePloS one2026
Excessive manganese content in children's multivitamin supplements: Potential for neurodevelopmental harm and other adverse health outcomes.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundManganese (Mn) is an essential nutrient vital for many physiological processes, but it can cause adverse health effects at high exposures, particularly during neurodevelopment. Mn is included in many children's multivitamins and mineral supplements, but it has not been documented whether the levels of Mn in such supplements are appropriate or safe. In this study, we measured Mn concentrations in children's multivitamin and mineral supplements and compared the concentrations to the Institute of Medicine's (IOM's) tolerable Upper intake Levels (ULs).
methodsWe purchased 52 multivitamin and mineral supplements in various forms, including tablets, capsules, gummies, powders, and liquids. Of these samples, half listed supplemental Mn on their labels; half did not. We quantified their manganese concentrations using inductively coupled plasma-optical emission spectroscopy. We compared the measured Mn concentrations of the samples to the labeled concentrations and to the IOM ULs.
resultsOf the 26 products with supplemental Mn on their labels, 23 (88.5%) contained more Mn than shown on the label, while 3 (11.5%) contained less. The mean percent difference between labeled and measured Mn content was 42.5%. One product (4%), a liquid, would exceed the IOM's Mn ULs based on labeled concentrations alone if consumed daily, 5 products (19%) would exceed IOM ULs based on measured concentrations, and 9 (34.6%) would exceed IOM ULs based on measured concentrations if used as supplements to ordinary diets. Of the 26 products without supplemental Mn listed on their labels, 13 (50.0%) contained measurable Mn concentrations. None of the products without supplemental Mn listed on their labels would exceed IOM ULs, even if consumed as supplements to ordinary diets.
conclusionsSome children's multivitamin supplements may lead to exceedances of IOM ULs for Mn, especially when consumed as supplements to ordinary diets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.